Skip to main content
# Title Department Research Year
831 Enhanced dispersive solid phase extraction assisted
by cloud point strategy prior to fluorometric
determination of anti-hepatitis C drug velpatasvir in
pharmaceutical tablets and body fluids
Department of Pharmaceutical Analytical Chemistry 2018
832 Efficient HPTLC-dual wavelength spectrodensitometric method for simultaneous determination of sofosbuvir and daclatasvir: Biological and pharmaceutical analysis Department of Pharmaceutical Analytical Chemistry 2018
833 Novel Targeted Lipid Nanoparticles Loaded with Synergistic Chemotherapy- Gene therapy Combination for Effective Treatment of Hepatocellular Carcinoma Department of Pharmaceutics 2018
834 A Localized Surface Plasmon Resonance Sensing Method for Simultaneous Determination of Atenolol and Amiloride in Pharmaceutical Dosage Forms and Urine Samples Department of Pharmaceutical Analytical Chemistry 2018
835 Novel N-Substituted 5-aminosalicylamides as Dual Inhibitors of Cyclooxygenase and 5-Lipoxygenase Enzymes: Synthesis, Biological Evaluation and Docking Study Department of Pharmaceutical Organic Chemistry 2018
836 Simultaneous quantitation of two direct acting hepatitis C antivirals (sofosbuvir and daclatasvir) by an HPLC-UV method designated for their pharmacokinetic study in rabbits Department of Pharmaceutical Analytical Chemistry 2018
837 Ultrasensitive Spectrofluorimetric Method for Rapid Determination of Daclatasvir and Ledipasvir in Human Plasma and Pharmaceutical Formulations Department of Pharmaceutical Analytical Chemistry 2018
838 Rapid Detection of Eight Volatile Alkaloids from Caryota mitis Lour. by LC-MS/MS and Antimicrobial Effects of their Extracts Department of Pharmacognosy 2018
839 Simultaneous quantitation of direct acting hepatitis c antiviral binary mixture via efficient HPLC-dual wavelength detection method Department of Pharmaceutical Analytical Chemistry 2018
840 ε-MnO2-modified graphite electrode as a novel electrochemical sensor
for the ultrasensitive detection of the newly FDA approved Hepatitis C
antiviral drug ledipasvir
Department of Pharmaceutical Analytical Chemistry 2018